Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 1
1981 1
1983 3
1984 2
1985 3
1986 2
1988 5
1989 1
1990 10
1991 5
1992 5
1993 1
1994 3
1995 4
1996 4
1997 5
1998 5
2000 7
2001 4
2002 6
2003 8
2004 6
2005 12
2006 4
2007 4
2008 7
2009 6
2010 6
2011 8
2012 2
2014 1
2015 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Results by year
Filters applied: . Clear all
Page 1
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D. Scagliotti GV, et al. Among authors: gatzemeier u. J Clin Oncol. 2008 Jul 20;26(21):3543-51. doi: 10.1200/JCO.2007.15.0375. Epub 2008 May 27. J Clin Oncol. 2008. PMID: 18506025 Clinical Trial.
Gatzemeier U, Griesinger F, Huber RM, Thomas M. Gatzemeier U, et al. Onkologie. 2008;31 Suppl 3:V. doi: 10.1159/000128573. Onkologie. 2008. PMID: 18545001 Free article. German. No abstract available.
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr. Hanna N, et al. Among authors: gatzemeier u. J Clin Oncol. 2004 May 1;22(9):1589-97. doi: 10.1200/JCO.2004.08.163. J Clin Oncol. 2004. PMID: 15117980 Clinical Trial.
Pemetrexed-cisplatin combination in mesothelioma.
Reck M, Gatzemeier U. Reck M, et al. Among authors: gatzemeier u. Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. doi: 10.1586/14737140.5.2.231. Expert Rev Anticancer Ther. 2005. PMID: 15877521 Review.
Tirapazamine-cisplatin: the synergy.
Gatzemeier U, Rodriguez G, Treat J, Miller V, von Roemeling R, Viallet J, Rey A. Gatzemeier U, et al. Br J Cancer. 1998 Jun;77 Suppl 4(Suppl 4):15-7. doi: 10.1038/bjc.1998.431. Br J Cancer. 1998. PMID: 9647615 Free PMC article. Review.
Chemotherapy in stage-IV NSCLC.
Reck M, Gatzemeier U. Reck M, et al. Among authors: gatzemeier u. Lung Cancer. 2004 Aug;45 Suppl 2:S217-22. doi: 10.1016/j.lungcan.2004.07.972. Lung Cancer. 2004. PMID: 15552802 Review.
Phase I trials of pemetrexed.
Fossella FV, Gatzemeier U. Fossella FV, et al. Among authors: gatzemeier u. Semin Oncol. 2002 Apr;29(2 Suppl 5):8-16. doi: 10.1053/sonc.2002.30764. Semin Oncol. 2002. PMID: 12023787 Review.
Pemetrexed in malignant pleural mesothelioma.
Gatzemeier U. Gatzemeier U. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):26-31. Oncology (Williston Park). 2004. PMID: 15655933 Free article. Review.
140 results